Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer
Condition(s):Triple Negative Breast CancerLast Updated:June 1, 2020Recruiting
Include Studies Not Open or Pending
Condition(s):Triple Negative Breast CancerLast Updated:June 1, 2020Recruiting
Condition(s):Plasma Cell MastitisLast Updated:September 7, 2022Recruiting
Condition(s):Olfactory DisorderLast Updated:July 11, 2022Recruiting
Condition(s):COVID-19Last Updated:January 9, 2023Not yet recruiting
Condition(s):Demyelinating Diseases of the Central Nervous System (DDC)Last Updated:June 13, 2022Not yet recruiting
Condition(s):Non-small Cell Lung Cancer Stage ILast Updated:October 28, 2021Recruiting
Condition(s):Proteinuria; Kidney Diseases; Hereditary NephropathyLast Updated:December 29, 2023Recruiting
Condition(s):Depressive, Symptoms Depressive Disorder, DepressionLast Updated:January 5, 2024Recruiting
Condition(s):Gastric AdenocarcinomaLast Updated:May 6, 2022Recruiting
Condition(s):Long COVIDLast Updated:October 26, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.